Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06910566 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy

Study acronym: TABAC STOP ORL
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Nov 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Secondary endpoints: details revised at 2 of 6 entriesv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The TABAC STOP ORL POUMON study aims to evaluate the factors influencing long-term smoking cessation in patients with head and neck cancer (HNC) or lung cancer undergoing radiotherapy or chemoradiotherapy. This is a single-center observational study, following patients at 1, 6, and 12 months after treatment completion. The primary objective is to determine the proportion of abstinent patients at 6 months, while secondary objectives analyze factors influencing abstinence, smoking trajectories, and reasons for relapse. A total of 100 patients will be included to ensure robust statistical analysis.
Trial Details
NCT Number NCT06910566
Lead Sponsor Centre Oscar Lambret
Conditions
(from sponsor)		 Smoking Cessation, Nicotine Addiction, Nicotine Dependence, Smoking, Head and Neck Neoplasms
Related terms Head and Neck Neoplasms, Smoking, Smoking Cessation, Tobacco Use Disorder
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov